The role of clinical microbiology service in antimicrobial stewardship_West China Medical Journal

Authors：

GAO Yulu ¹ , DAI Yuanyuan ² ,  MA Xiaoling ²

1. Depatment of Medical Laboratory, Kunshan Affiliated Hospital of Nanjing University of Chinese Medicine, Kunshan, Jiangsu 215300, P. R. China;
2. Depatment of Medical Laboratory, First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui 230000,P. R. China;

Corresponding?author：

MA Xiaoling, Email: maxiaoling@ustc.edu.cn

Keywords：

Clinical microbiology service; Antimicrobial stewardship; Antimicrobial susceptibility test

DOI：

10.7507/1002-0179.202006374

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Inappropriate and irrational prescription of antimicrobial agents has led to increasing bacterial resistance, which has become a major concern around the world. Clinical microbiology service provides a basis and guarantee for the rational application of antimicrobial agents and an important technical support for antimicrobial stewardship, and plays an important role in promoting the rational use of antimicrobial agents. This paper summarizes and evaluates the specific role and technical requirements of clinical microbiology service in the diagnosis of infectious diseases, rational application of antimicrobial agents, hospital infection control and training of medical staff, so as to provide a technical guidance for clinical microbiology service in the antimicrobial stewardship.

Citation： GAO Yulu, DAI Yuanyuan, MA Xiaoling. The role of clinical microbiology service in antimicrobial stewardship. West China Medical Journal, 2020, 35(8): 889-893. doi: 10.7507/1002-0179.202006374 Copy

1.	Aslam B, Wang W, Arshad MI, <italic>et al</italic>. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist, 2018, 11: 1645-1658.
2.	McGann P, Snesrud E, Maybank R, <italic>et al</italic>. Erratum for McGann <italic>et al</italic>., <italic>Escherichia coli</italic> harboring <italic>mcr-1</italic> and <italic>bla</italic><sub>CTX-M</sub> on a novel IncF plasmid: first report of <italic>mcr-1</italic> in the United States. Antimicrob Agents Chemother, 2016, 60(8): 5107.
3.	Hernando-Amado S, Coque TM, Baquero F, <italic>et al</italic>. Defining and combating antibiotic resistance from one health and global health perspectives. Nat Microbiol, 2019, 4(9): 1432-1442.
4.	國家衛生和計劃生育委員會, 國家發展改革委員會, 教育部, 等. 遏制細菌耐藥國家行動計劃(2016-2020年). 藥物不良反應雜志, 2016, 18(5): 398-400.
5.	中華人民共和國國家衛生和計劃生育委員會. 關于持續做好抗菌藥物臨床應用管理有關工作的通知. 中國實用鄉村醫生雜志, 2018, 25(6): 1-2.
6.	Morency-Potvin P, Schwartz DN, Weinstein RA. Antimicrobial stewardship: how the microbiology laboratory can right the ship. Clin Microbiol Rev, 2016, 30(1): 381-407.
7.	中華人民共和國國家健康委員會. 抗菌藥物敏感性試驗的技術要求: WS/T 639－2018, 2018.
8.	Ashiru-Oredope D, Sharland M, Charani E, <italic>et al</italic>. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus. J Antimicrob Chemother, 2012, 67(Suppl 1): i51-i63.
9.	中華人民共和國國家健康委員會. 臨床微生物學檢驗標本的采集和轉運: WS/T 640－2018, 2018.
10.	中國醫師協會檢驗醫師分會感染性疾病檢驗醫學專家委員會, 中國醫院協會臨床檢驗管理專業委員會, 中華醫學會檢驗醫學分會臨床微生物專業學組. 中國三級甲等綜合醫院檢驗醫學微生物學組(科)建設專家共識. 中華檢驗醫學雜志, 2016, 39(8): 581-584.
11.	馬筱玲, 胡繼紅, 徐英春, 等. 臨床微生物學實驗室建設基本要求專家共識. 中華檢驗醫學雜志, 2016, 39(11): 820-823.
12.	中國合格評定國家認可委員會. CNAS-CL02-A005: 2018醫學實驗室質量和能力認可準則在臨床微生物檢驗領域的應用說明. (2018-03-01)[2020-06-01]. https://www.cnas.org.cn/rkgf/sysrk/rkyyzz/2018/03/889106.shtml.
13.	Barenfanger J. Quality assurances: decreasing clinically irrelevant testing from clinical microbiology laboratories, part II. Clin Microbiol Newsl, 2006, 28(4): 25-29.
14.	Dellit TH, Owens RC, Mcgowan JE Jr, <italic>et al</italic>. Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis, 2007, 44(2): 159-177.
15.	Ohl CA, Luther VP. Health care provider education as a tool to enhance antibiotic stewardship practices. Infect Dis Clin North Am, 2014, 28(2): 177-193.
16.	Ovia?o M, Rodríguez-Sánchez B. MALDI-TOF mass spectrometry in the 21st century clinical microbiology laboratory. Enferm Infecc Microbiol Clin, 2020: S0213-005X(20)30163-4.
17.	Woo PC, Lau SK, Teng JL, <italic>et al</italic>. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. Clin Microbiol Infect, 2008, 14(10): 908-934.
18.	Jonasson E, Matuschek E, Kahlmeter G. The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles. J Antimicrob Chemother, 2020, 75(4): 968-978.
19.	Idelevich EA, Becker K. How to accelerate antimicrobial susceptibility testing. Clin Microbiol Infect, 2019, 25(11): 1347-1355.
20.	Inglis T, Ekelund O. Rapid antimicrobial susceptibility tests for sepsis; the road ahead. J Med Microbiol, 2019, 68(7): 973-977.
21.	Grohs P, Rondinaud E, Fourar M, <italic>et al</italic>. Comparative evaluation of the QMAC-dRAST V2.0 system for rapid antibiotic susceptibility testing of Gram-negative blood culture isolates. J Microbiol Methods, 2020, 172: 105902.
22.	Australian Commission on Safety and Quality in Health Care. Antimicrobial stewardship in australian health care 2018. Sydney: Australian Commission on Safety and Quality in Health Care, 2018[2020-06-01]. https://www.safetyandquality.gov.au/publications-and-resources/resource-library/antimicrobial-stewardship-australian-health-care-2018.

1. Aslam B, Wang W, Arshad MI, <italic>et al</italic>. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist, 2018, 11: 1645-1658.
2. McGann P, Snesrud E, Maybank R, <italic>et al</italic>. Erratum for McGann <italic>et al</italic>., <italic>Escherichia coli</italic> harboring <italic>mcr-1</italic> and <italic>bla</italic><sub>CTX-M</sub> on a novel IncF plasmid: first report of <italic>mcr-1</italic> in the United States. Antimicrob Agents Chemother, 2016, 60(8): 5107.
3. Hernando-Amado S, Coque TM, Baquero F, <italic>et al</italic>. Defining and combating antibiotic resistance from one health and global health perspectives. Nat Microbiol, 2019, 4(9): 1432-1442.
4. 國家衛生和計劃生育委員會, 國家發展改革委員會, 教育部, 等. 遏制細菌耐藥國家行動計劃(2016-2020年). 藥物不良反應雜志, 2016, 18(5): 398-400.
5. 中華人民共和國國家衛生和計劃生育委員會. 關于持續做好抗菌藥物臨床應用管理有關工作的通知. 中國實用鄉村醫生雜志, 2018, 25(6): 1-2.
6. Morency-Potvin P, Schwartz DN, Weinstein RA. Antimicrobial stewardship: how the microbiology laboratory can right the ship. Clin Microbiol Rev, 2016, 30(1): 381-407.
7. 中華人民共和國國家健康委員會. 抗菌藥物敏感性試驗的技術要求: WS/T 639－2018, 2018.
8. Ashiru-Oredope D, Sharland M, Charani E, <italic>et al</italic>. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus. J Antimicrob Chemother, 2012, 67(Suppl 1): i51-i63.
9. 中華人民共和國國家健康委員會. 臨床微生物學檢驗標本的采集和轉運: WS/T 640－2018, 2018.
10. 中國醫師協會檢驗醫師分會感染性疾病檢驗醫學專家委員會, 中國醫院協會臨床檢驗管理專業委員會, 中華醫學會檢驗醫學分會臨床微生物專業學組. 中國三級甲等綜合醫院檢驗醫學微生物學組(科)建設專家共識. 中華檢驗醫學雜志, 2016, 39(8): 581-584.
11. 馬筱玲, 胡繼紅, 徐英春, 等. 臨床微生物學實驗室建設基本要求專家共識. 中華檢驗醫學雜志, 2016, 39(11): 820-823.
12. 中國合格評定國家認可委員會. CNAS-CL02-A005: 2018醫學實驗室質量和能力認可準則在臨床微生物檢驗領域的應用說明. (2018-03-01)[2020-06-01]. https://www.cnas.org.cn/rkgf/sysrk/rkyyzz/2018/03/889106.shtml.
13. Barenfanger J. Quality assurances: decreasing clinically irrelevant testing from clinical microbiology laboratories, part II. Clin Microbiol Newsl, 2006, 28(4): 25-29.
14. Dellit TH, Owens RC, Mcgowan JE Jr, <italic>et al</italic>. Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis, 2007, 44(2): 159-177.
15. Ohl CA, Luther VP. Health care provider education as a tool to enhance antibiotic stewardship practices. Infect Dis Clin North Am, 2014, 28(2): 177-193.
16. Ovia?o M, Rodríguez-Sánchez B. MALDI-TOF mass spectrometry in the 21st century clinical microbiology laboratory. Enferm Infecc Microbiol Clin, 2020: S0213-005X(20)30163-4.
17. Woo PC, Lau SK, Teng JL, <italic>et al</italic>. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. Clin Microbiol Infect, 2008, 14(10): 908-934.
18. Jonasson E, Matuschek E, Kahlmeter G. The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles. J Antimicrob Chemother, 2020, 75(4): 968-978.
19. Idelevich EA, Becker K. How to accelerate antimicrobial susceptibility testing. Clin Microbiol Infect, 2019, 25(11): 1347-1355.
20. Inglis T, Ekelund O. Rapid antimicrobial susceptibility tests for sepsis; the road ahead. J Med Microbiol, 2019, 68(7): 973-977.
21. Grohs P, Rondinaud E, Fourar M, <italic>et al</italic>. Comparative evaluation of the QMAC-dRAST V2.0 system for rapid antibiotic susceptibility testing of Gram-negative blood culture isolates. J Microbiol Methods, 2020, 172: 105902.
22. Australian Commission on Safety and Quality in Health Care. Antimicrobial stewardship in australian health care 2018. Sydney: Australian Commission on Safety and Quality in Health Care, 2018[2020-06-01]. https://www.safetyandquality.gov.au/publications-and-resources/resource-library/antimicrobial-stewardship-australian-health-care-2018.

Previous Article
頸胸腹骨盆會陰鋼筋貫通傷醫療聯合體多學科救治一例
Next Article
Progress in the laboratory detection and clinical research of cryptococcosis

West China Medical Journal

The role of clinical microbiology service in antimicrobial stewardship

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content